Rallybio Corporation creates treatments for rare and severe health conditions, focusing on blood disorders and eye diseases. Their main work involves testing new antibody therapies through clinical trials and partnerships with other pharmaceutical companies. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
